Cargando…

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales:	Quinto, C.J., Pamittan, J.M., Paraguison, C.A., Peralta, M.J., Perdido, H.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164597/ http://dx.doi.org/10.1016/j.diabres.2022.109341

Ejemplares similares

IDF21-0542 Sharing “a.ma.dia” Experiences of how the Institution Have Faced COVID-19 Issues
por: Ramamonjisoa, H.A., et al.
Publicado: (2022)

IDF21-0678 Telemedicine Use and Selfmanagement Behaviors of Persons with Type 2 DM in Luzon Philippines during the COVID-19 Pandemic
por: Abaigar Jr., M., et al.
Publicado: (2022)

Phylogenetic tracking of current porcine epidemic diarrhea virus (PEDV) strains in the Philippines
por: Paraguison-Alili, Rubigilda, et al.
Publicado: (2016)

Identification of a Highly Conserved Hypothetical Protein TON_0340 as a Probable Manganese-Dependent Phosphatase
por: Sohn, Young-Sik, et al.
Publicado: (2016)

EHMTI-0340. Distance treatment programs for individuals with complex chronic headaches living far from the hospital: the Canadian experience
por: Dick, B, et al.
Publicado: (2014)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0288 Virtually Sugar Free: Overcoming Challenges of Managing Gestational Diabetes (GDM) during a Pandemic
por: Khurana, R., et al.
Publicado: (2022)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0616 Observational study on covid 19 and type 1 diabetes in the Chronic Care Center Lebanon
por: Maalouf Nawfal, P., et al.
Publicado: (2022)

IDF21-0472 The effect of structured diabetes self-management education care on glycaemic control in Accra subsequent to COVID-19
por: Lamptey, R., et al.
Publicado: (2022)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0636 Effects of COVID-19 lockdown on lifestyle changes and medical challenges in patients with type 1 diabetes in south India
por: Guha Pradeepa, R.P., et al.
Publicado: (2022)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

IDF21-0567 Analysis of mortality and cardio-metabolic comorbidities in Covid-19 patients from Eastern European region
por: Popescu, I., et al.
Publicado: (2022)

IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
por: Veríssimo, D., et al.
Publicado: (2022)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU
por: Capellan, N., et al.
Publicado: (2022)

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection
por: Babic, I., et al.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0220 Hypertension as a Prognostic Factor in the Prediction of Mortality in Patients with COVID-19: A Meta-Analysis
por: Juangco, J.R., et al.
Publicado: (2022)

IDF21-0510 Human Serum Metabolites as Potential Mediators from Obesity to COVID-19: A Network Mendelian Randomization Study
por: Huang, C., et al.
Publicado: (2022)

IDF21-0512 Development of Latent Autoimmune Diabetes of Adults Post SARS-COV-2 mRNA Vaccination
por: Kanzy, A., et al.
Publicado: (2022)

IDF21-0498 Innovative ways to continue serving People with Type 1 Diabetes during Covid 19 pandemic
por: Abi Saad, M., et al.
Publicado: (2022)

IDF21-0377 Evaluation of the glycemic profile during 6 months after hospital discharge of patients with severe COVID-19
por: Lima, M., et al.
Publicado: (2022)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report
por: Gonzalez, L., et al.
Publicado: (2022)

The Heroes of the I.D.F.
por: Gotweter, Y.
Publicado: (1967)

IDF21-0363 Evaluation of virtual consultation and patient satisfaction during COVID-19 – Survey at the Chronic Care Center, Lebanon
por: Rayes Sadek, C., et al.
Publicado: (2022)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait
por: Aljuailla, F., et al.
Publicado: (2022)

IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis
por: Forouhari, A., et al.
Publicado: (2022)

IDF21-0564 The Use of a Digital Self-Care Platform in The Control of Diabetes in People With Diabetes During the COVID-19 Pandemic
por: Jacobs, M., et al.
Publicado: (2022)

IDF21-0521 Peer Support for Diabetes Management in the Shanghai Integration Model Developed Community Capacity to Combat COVID-19
por: Liu, Y., et al.
Publicado: (2022)

IDF21-0452 Virtual Diabetes Education Program for Children and Adolescents with Diabetes in Response to COVID-19 Pandemic
por: Alromaihi, D., et al.
Publicado: (2022)

IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic
por: Almutairi, M., et al.
Publicado: (2022)

IDF21-0230 Anti-inflammatory activity of glyoxalase-1 inducer supports further evaluation for prevention of COVID-19
por: Xue, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c8sjj0q8hq6s5rdsj40ate0616